Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials.

Clinical Cancer Research

1 janvier 2014
Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials.

Ferté C, Fernandez M, Hollebecque A, Koscielny S, Levy A, Massard C, Balheda R, Bot B, Gomez-Roca C, Dromain C, Ammari S, Soria JC.